Clopidogrel for Proteinuria Reduction in Focal Segmental Glomerulosclerosis: Phase 2 Trial Design

  • Lisa Daniel-Fischer
  • , Marlies Antlanger
  • , Daniel Cejka
  • , Kathrin Eller
  • , Philipp Gauckler
  • , Balazs Odler
  • , Michael Rudnicki
  • , Marcus D Säemann
  • , Alice Schmidt
  • , Gere Sunder-Plassmann
  • , Martin Wiesholzer
  • , Martin Windpessl
  • , Emanuel Zitt
  • , Franz Koenig
  • , Larry A Greenbaum
  • , Andreas Kronbichler
  • , Christoph Aufricht*
  • *Corresponding author for this work

Research output: Journal article (peer-reviewed)Letter/short communication

Original languageEnglish
Pages (from-to)478-481
Number of pages4
JournalKidney International Reports
Volume9
Issue number2
DOIs
Publication statusPublished - 02 Feb 2024

Keywords

  • FSGS
  • clopidogrel
  • drug repurposing
  • proteinuria

ASJC Scopus subject areas

  • Nephrology

Cite this